Tag: Drug
Business & Industry
Gilead Secures GH31 Global Rights in $80M Oncology Deal
Gilead Sciences has added another synthetic lethal asset to its oncology portfolio, agreeing to pay $80 million upfront to obtain global rights to a...
Clinical Trials
AstraZeneca Breztri Reports Positive Phase III Trial Results
Results from the Phase III KALOS and LOGOS trials evaluating AstraZeneca Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) in patients with uncontrolled asthma have...
Business & Industry
Novartis Breaks Ground on San Diego Biomedical R&D Site
Novartis has started work on a $1.1 billion biomedical research facility in California, adding a major new pillar to its long-term US investment strategy....
Business & Industry
Innovent-Lilly Partnership Expands Global Drug Development
Innovent Biologics has announced a strategic Innovent-Lilly partnership with Eli Lilly and Company to advance the global development of new medicines in oncology and...
Business & Industry
Halo Pharma Emerges as the North American Drug Product CDMO
Halo Pharma becomes dedicated North American drug product CDMO after emerging as a standalone contract development and manufacturing organization focused exclusively on drug product...
News
Vetter Pharma to Build New Manufacturing Site in Germany
Vetter Pharma manufacturing site in Germany plans have been confirmed as the pharmaceutical service provider moves forward with building a new commercial production facility...
Business & Industry
Drugmakers Turn to AI To Speed Up Trials and Submissions
Drugmakers turn to AI as a practical way to reduce delays in clinical trials and regulatory submissions, even as artificial intelligence has yet to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
